NEMAURA MED INC's ticker is NMRD and the CUSIP is 640442208. A total of 16 filers reported holding NEMAURA MED INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,422 | -65.9% | 26,737 | 0.0% | 0.00% | – |
| Q2 2023 | $24,734 | +3.4% | 26,737 | 0.0% | 0.00% | – |
| Q1 2023 | $23,930 | -22.4% | 26,737 | +48.9% | 0.00% | – |
| Q4 2022 | $30,824 | -16.7% | 17,951 | 0.0% | 0.00% | – |
| Q3 2022 | $37,000 | -19.6% | 17,951 | 0.0% | 0.00% | – |
| Q2 2022 | $46,000 | -41.0% | 17,951 | 0.0% | 0.00% | – |
| Q1 2022 | $78,000 | -4.9% | 17,951 | 0.0% | 0.00% | – |
| Q4 2021 | $82,000 | -24.1% | 17,951 | 0.0% | 0.00% | – |
| Q3 2021 | $108,000 | -41.9% | 17,951 | 0.0% | 0.00% | – |
| Q2 2021 | $186,000 | -71.0% | 17,951 | -78.6% | 0.00% | – |
| Q1 2021 | $641,000 | +106.1% | 83,841 | +1.7% | 0.00% | – |
| Q4 2020 | $311,000 | +7.2% | 82,442 | +0.9% | 0.00% | – |
| Q3 2020 | $290,000 | -58.9% | 81,683 | +7.1% | 0.00% | – |
| Q2 2020 | $705,000 | – | 76,255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIGER MANAGEMENT L.L.C. | 375,000 | $643,913 | 0.24% |
| ARS Investment Partners, LLC | 78,269 | $134,396 | 0.02% |
| VANGUARD GROUP INC | 130,861 | $224,702 | 0.00% |
| UBS Group AG | 5,148 | $8,854 | 0.00% |
| NewEdge Advisors, LLC | 360 | $1 | 0.00% |
| HAZLETT, BURT & WATSON, INC. | 30 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3,117 | $5,352 | 0.00% |
| NORTHERN TRUST CORP | 17,951 | $30,824 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 107,897 | $183 | 0.00% |